cetapred opth.oint. eye ointment
alcon couvreur - prednisolone, sulfacetamide - eye ointment - 10, 0.25 %
cetapred eye oint.
alcon-scientific office - eye ointment
isopto-cetapred eye drops
alcon belgium - eye drops
isoptocetapred eye drops
alcon couvreur - prednisolone, sulfacetamide - eye drops - 10, 0.25, 0.5 %
isopto cetapred
electramed ireland limited - prednisolone acetate sulfacetamide sodium -
isopto cetapred 2,50 mg/ml - 100 mg/ml eye drops susp. dropper cont.
novartis pharma sa-nv - prednisolone acetate 2,5 mg/ml; sulfacetamide sodium 100 mg/ml - eye drops, suspension - prednisolone and antiinfectives
catapres-tts
carsl consulting - clonidine 2.5mg - transdermal patch - 2.5 mg - active: clonidine 2.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.
catapres-tts
carsl consulting - clonidine 5mg - transdermal patch - 5 mg - active: clonidine 5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.
catapres-tts
carsl consulting - clonidine 7.5mg - transdermal patch - 7.5 mg - active: clonidine 7.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.
catapres clonidine hydrochloride 150 microgram/1ml injection ampoule
clinect pty ltd - clonidine hydrochloride, quantity: 150 microgram/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - indications as at 16 may 2001: parenteral: acute hypertensive crisis. as an alternative to oral therapy where the oral route of administration is inappropriate.